Exagen Inc. (XGN) Financials

XGN Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 56.9 million 34.3 million
2023-09-30 60.9 million 33.4 million
2023-06-30 64.2 million 32.3 million
2023-03-31 79.2 million 43.3 million

XGN Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 8.2 million 763000
2023-09-30 -2.9 million 890000
2023-06-30 -10.5 million 978000
2023-03-31 -10.1 million 986000

XGN Net Income

No data available :(

XGN Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 36.5 million - 4.2 million
2023-09-30 28.4 million - 4.8 million
2023-06-30 31.5 million - 5.0 million
2023-03-31 52.2 million - 5.3 million

XGN Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 17.8 million
2023-09-30 17.7 million
2023-06-30 17.7 million
2023-03-31 17.5 million

XGN Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 106000 1.1 million 12.2 million -
2023-09-30 2000 1.4 million 10.9 million 500000
2023-06-30 324000 1.3 million 11.6 million 400000
2023-03-31 396000 1.1 million 11.6 million 300000

XGN Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 13.8 million 5.6 million
2023-09-30 13.4 million 5.7 million
2023-06-30 14.1 million 5.8 million
2023-03-31 11.2 million 5.9 million

XGN

Price: $1.40

52 week price:
1.33
3.92

Earnings Per Share: -1.34 USD

P/E Ratio: -1.11

Exchange: NGM

Sector: Healthcare

Industry: Diagnostics & Research

Volume: 10300

Market Capitalization: 25.5 million

Links: